EpCAM

Related by string. Ep CAM * * adhesion molecule EpCAM . EpCAM expression . targets EpCAM expressing . adhesion molecule EpCAM expressing . targeting EpCAM CD# *

Related by context. All words. (Click for frequent words.) 73 CD# molecule 72 WT1 72 CD# [002] 72 EGFr 71 carcinoembryonic antigen 71 cytokeratin 71 MAGE A3 71 CD# antigen 70 tumor antigen 70 HER2 receptor 70 GPNMB 69 Ki# 69 peripheral blood mononuclear 69 CCR9 69 mesothelin 69 HER2/neu 69 TRAIL R2 68 VEGF receptor 68 effector function 68 N cadherin 68 HAAH 68 CanAg 68 BRAF mutation 68 vimentin 68 ALDH 68 milatuzumab 68 survivin 68 immunohistochemical staining 68 somatostatin receptors 68 MAb 67 folate receptor 67 epithelial tumors 67 Eg5 67 SIRT2 67 PPARgamma 67 IgG1 antibody 67 depsipeptide 67 PC# cells 67 ovarian carcinoma 67 EphA2 67 peptide antigens 67 HER-2/neu 67 MUC1 67 S#A# [002] 67 NKG2D 67 IGF 1R 67 ErbB3 67 miR #a [001] 67 targeting CD# 67 CD# CD# 67 tumorigenicity 67 EGFR tyrosine kinase inhibitors 67 aberrantly activated 67 androgen receptor AR 67 VEGFR2 66 EGF receptor 66 activated lymphocytes 66 ERalpha 66 Sym# 66 T#I [002] 66 EGFR HER2 66 Akt activation 66 Mesothelin 66 TRAIL R1 66 iNOS 66 homodimers 66 xenografts 66 TNF α 66 clusterin 66 FLT3 66 Annexin V 66 KRAS mutations 66 IgG1 66 autoantibody 66 CD# protein 66 B7 H3 66 cisplatin resistant 66 Immunohistochemical analysis 66 surface glycoprotein 66 Her2/neu 66 myeloma cells 66 xenograft models 66 pDCs 66 TTR gene 66 NSCLC tumors 66 nucleolin 66 humanized anti 66 colon carcinoma 66 HLA DR 66 TNFa 65 EGFRvIII 65 A3 adenosine receptor 65 TRAIL induced apoptosis 65 c MYC 65 vWF 65 TNFalpha 65 XL# inhibits 65 SPINK1 65 microRNA miR 65 IgG antibodies 65 M2 subunit 65 EGFR inhibitors 65 constitutively 65 IFN gamma 65 INGN 65 HER3 65 TIMP 1 65 cytotoxicity 65 PI3K Akt 65 mRNA expression 65 EGFR mutations 65 PDGFR 65 antiproliferative effects 65 pro angiogenic 65 immunoreactivity 65 cell adhesion molecule 65 HER2 ErbB2 65 CagA 65 hCG beta 65 IL #E 65 P selectin 65 CD# receptor 65 Epidermal Growth Factor Receptor 65 HER2 overexpression 65 IL #p# 65 nanomolar 65 activin 65 annexin V 65 biodistribution 65 MGd 65 B7 H4 65 K ras mutations 65 pan HDAC inhibitor 65 hypoxia inducible factor 65 IGF1R 65 tyrosine kinase receptor 65 HCV protease 65 Clusterin 65 pro apoptotic 65 HEK# cells 65 induces apoptosis 65 lymphoid cells 65 IGF IR 65 PC3 cells 65 miRs 65 Fibroblast Growth Factor Receptor 65 colorectal carcinoma 65 promoter methylation 65 transfected 65 seliciclib 65 mutational status 65 FGFR 65 UsiRNAs 65 EphB4 65 bispecific antibody 65 carcinoembryonic antigen CEA 65 miRNA expression 65 caveolin 1 65 PI3K inhibitors 65 ERK1 2 64 somatostatin receptor 64 phosphate S1P 64 antitumor activity 64 EGFR 64 p#INK#a 64 hepatoma 64 activating mutations 64 estrogen receptor ER 64 prostate carcinoma 64 EGFR protein 64 immunostimulatory 64 ERK signaling 64 CCX# 64 antiangiogenic 64 Epratuzumab 64 pancreatic adenocarcinoma 64 chemokine receptor 64 immunohistochemical 64 proto oncogene 64 ENMD # 64 VEGFR 64 ErbB 64 TIMP 64 TRAIL receptors 64 CD# + [002] 64 tumor xenograft models 64 IL #R 64 TGF β 64 hTERT 64 anti CD3 64 humanized antibody 64 CLL cells 64 TOP2A 64 transfected cells 64 PBMCs 64 compound AEZS 64 HER2 antibody 64 HER2 positive metastatic breast 64 CXCR7 64 PI3K inhibitor 64 CTGF 64 panobinostat 64 HGS ETR2 64 cyclin E 64 bcl 2 64 epithelial cancers 64 interleukin IL -# 64 JAK inhibitors 64 protein tyrosine phosphatase 1B 64 tumor xenografts 64 APOPTONE 64 monoclonal 64 preclinically 64 #F FDG PET 64 TNFα 64 PKCi 64 methylated DNA 64 CD#c 64 syngeneic 64 NY ESO 64 thymidylate synthase TS 64 cathepsin B 64 gastrin 64 Notch1 64 EGFR mutation 64 PTP 1B 64 isotype 64 vitro cytotoxicity 64 5alpha reductase 64 CCR2 64 Aurora kinase 64 Trp p8 64 LHRH receptors 64 mGlu2 3 64 Foxp3 64 Cytotoxic T 63 antiangiogenic therapy 63 p#HER# 63 E#F# 63 flavopiridol 63 labetuzumab 63 XmAb# 63 Gleevec resistant 63 qRT PCR 63 oral prodrug 63 S1P 63 EGFR expression 63 serum antibodies 63 antibody MT# 63 STAT3 63 CD# antibody [001] 63 antibody MAb 63 FGFR4 63 MMP9 63 TG# [003] 63 oncoprotein 63 CD# + [001] 63 selective inhibition 63 Beta catenin pathway 63 PI3 kinase 63 investigational humanized monoclonal antibody 63 tumor specific antigen 63 CEACAM1 63 immunostaining 63 CCL# 63 selective kinase inhibitor 63 hENT1 63 Tie2 63 AAV2 63 c MET 63 uPAR 63 ERBB2 63 CYC# 63 Carfilzomib 63 IL 1beta 63 virulence genes 63 HepG2 cells 63 beta subunit 63 glioma cells 63 CTLA 4 63 MAPK pathway 63 BRAF V#E mutation 63 VSV G 63 HDACi 63 TRAIL receptor 63 potent inhibitory 63 HIF 1alpha 63 CD#b 63 VEGFR1 63 RRM1 63 extracellular domain 63 EGFP 63 radiolabeled 63 intratumoral injection 63 predictive biomarker 63 Mucosal 63 cytoprotective 63 specific lectin receptors 63 neuroblastoma tumors 63 Immunohistochemical staining 63 glioblastoma cells 63 CD1d 63 P cadherin 63 BCR ABL 63 FasL 63 TGF ß 63 CXCR4 63 splice variants 63 PXD# 63 HIF 1a 63 breast carcinomas 63 Stat5 63 hematopoietic cells 63 IGFBP 3 63 p#Kip# 63 imatinib Gleevec ® 63 constitutively active 63 costimulatory 63 Cyclin E 63 humanized monoclonal antibody 63 pCR 63 pertussis toxin 63 plasmacytoid dendritic cells 63 Factor Receptor 63 IL 1ß 63 GRP# 63 HER2 protein 63 Azedra 63 tumor antigens 63 orally bioavailable 63 miR #a [002] 63 AT1R 63 eIF 4E 62 delta isoform 62 EGFR antibodies 62 Rap1 62 Hsp# inhibition 62 c Src 62 favorable pharmacokinetic profile 62 NOD SCID mice 62 phosphoprotein 62 selective modulator 62 anticancer activity 62 anti EGFR antibody 62 chemosensitivity 62 antisense inhibition 62 adenocarcinomas 62 NFκB 62 pDC 62 IL6 62 CD# monoclonal antibody 62 HER2 expression 62 chemoattractant 62 alveolar epithelial cells 62 gene amplification 62 IL 1β 62 lysophosphatidic acid LPA 62 receptor CD# 62 metastatic RCC 62 selective agonist 62 inhibitory receptor 62 neuropilin 62 NKX#.# 62 IFN γ 62 HIF 1α 62 MLL AF9 62 metastatic renal cell carcinoma 62 tumoral 62 serine protease 62 MET amplification 62 p# MAPK 62 thyroglobulin 62 mouse xenograft models 62 Kahalalide F 62 Fas ligand 62 adhesion molecule 62 binds selectively 62 thioredoxin 62 MDM2 62 chemoresistant 62 mitogen activated protein kinase 62 HSP# 62 MORAb 62 murine 62 Aplidin 62 BAL# [001] 62 myeloperoxidase 62 MAP kinase 62 oncoproteins 62 GRN#L 62 MDA MB 62 trans retinoic acid 62 Upregulation 62 ON #.Na 62 molecular biomarkers 62 NS4A 62 pulmonary metastases 62 LNCaP cells 62 humanised antibody 62 P#X# 62 potent antiproliferative 62 SOX9 62 LHRH 62 FGFR1 62 EGF receptors 62 HuLuc# 62 Amphinex ® 62 CCN2 62 BRAF mutations 62 adecatumumab 62 NS#/#A protease 62 CD# expression [002] 62 VEGF expression 62 ErbB2 62 TRAIL Receptor 62 fluoropyrimidine 62 telomerase reverse transcriptase 62 solithromycin 62 NFkB 62 receptor tyrosine kinase 62 inhibitory effects 62 K ras 62 CYT# potent vascular disrupting 62 neuroblastoma cells 62 orally administered inhibitor 62 EGFR mutant 62 isotypes 62 myelofibrosis polycythemia vera 62 HGS ETR1 62 B7 H1 62 CD8 + 62 TLR8 62 IFN alpha 62 malignant prostate 62 gefitinib 62 CD# expressing 62 glycosylated 62 HER2 62 EGFR HER 62 TGF alpha 62 elastase 62 immunoblotting 62 microvessel density 62 EGFR receptor 62 potent inhibitor 62 CTLs 62 chimeric monoclonal antibody 62 monomeric 62 deacetylation 62 PARP inhibition 62 TGF beta1 62 RAV# 62 alpha folate receptor 62 interferon IFN 62 tyrosine kinase inhibitor 62 hepatocellular carcinomas 62 cytotoxin 62 tNOX 62 Nod1 62 potent inhibition 62 HBx 62 VEGF receptors 62 gastrointestinal stromal tumors GISTs 62 CD# antibodies 62 epithelial markers 62 transgene expression 62 monocytes macrophages 62 OXi# 62 trastuzumab 62 castrate resistant prostate cancer 62 Imprime PGG 62 ChR2 62 EZH2 62 LHRH receptor 62 Anticalins ® 62 IGFBP2 62 aT cell 62 antiangiogenic activity 62 microglial activation 62 tryptase 62 NF kB pathway 62 somatostatin 62 Traficet EN 62 therapeutically relevant 62 anti apoptotic proteins 62 replicon 62 Blinatumomab 62 mature dendritic cells 62 Protein Kinase C 62 bronchial epithelial cells 62 NF kappaB activation 62 TrkA 62 huC# DM4 62 sodium glucose cotransporter 62 galectins 62 phosphatidylinositol 3 62 CCR7 62 erlotinib Tarceva ® 62 DNA intercalator 62 prognostic markers 62 cells transfected 62 transmembrane protein 62 murine model 62 cMET 61 busulfan 61 ER alpha 61 IFN α 61 prostate epithelial cells 61 monocytic 61 MAbs 61 adrenocortical 61 PKC# 61 5 HT4 receptor 61 μg ml 61 AEG# 61 PDGF 61 Virulizin ® 61 TLR9 61 eNOS 61 immunoreactive 61 alkaline phosphatase ALP 61 keratinocyte 61 antibody responses 61 oncogenic 61 mediated apoptosis 61 isoform 61 antiapoptotic 61 catenin 61 selective inhibitor 61 SGLT2 61 retinoic acid receptor 61 GM CSF 61 Gefitinib 61 MEK ERK 61 ELISPOT 61 histone deacetylase HDAC inhibitor 61 CD#L 61 Symadex 61 constitutively activated 61 adenoviral 61 FK# 61 antitumor 61 lymph node metastasis 61 epitope 61 ErbB2 positive 61 FOXP3 61 kDa protein 61 mapatumumab 61 regulated kinase 61 myeloproliferative diseases 61 E. faecalis 61 FUS1 61 protein tyrosine kinase 61 interleukin IL 61 receptors EGFR 61 DAVANAT 61 co stimulatory molecules 61 trabectedin 61 lymphoma subtypes 61 Hsp# Inhibitor 61 lung carcinomas 61 CD4 + CD# 61 RANTES 61 receptor CXCR4 61 renal cell carcinomas 61 p# antigen 61 anti proliferative 61 ADAMTS# 61 immunoregulatory 61 imetelstat 61 TLR7 61 Her2 61 TGF b 61 lymph node metastases 61 xenograft tumors 61 c myc 61 Proxinium TM 61 AhR 61 tumor subtypes 61 lymphotoxin 61 p# Shc 61 EGFR TKI 61 mutant p# 61 ligand TRAIL 61 prostate cancer PCa 61 HDAC6 61 sunitinib Sutent ® 61 PI3K delta 61 HOXB# 61 V#F 61 solid tumors 61 selectively inhibited 61 downregulated 61 PSMA ADC 61 fosbretabulin 61 highly immunogenic 61 FGFR2 61 HCV replicon 61 HER2 receptors 61 HDAC 61 Cdc7 61 grade cervical intraepithelial 61 FDG PET 61 RNase L 61 neutralizing antibodies 61 tumorigenic 61 gastric carcinoma 61 IMC A# 61 antigen CD# 61 anti apoptotic 61 bleomycin 61 transduced 61 micronuclei 61 luteinizing hormone releasing 61 chloride secretion 61 p#NTR 61 murine monoclonal antibody 61 GAP #B# 61 61 Multimeric 61 melatonin receptor 61 Xanafide 61 peroxidase 61 Cathepsin B 61 tubulin polymerization 61 BiTE antibody 61 M2PK 61 ERCC1 61 anti angiogenic drugs 61 vitro assay 61 PSMA protein 61 PDGF receptor 61 1beta 61 apoptotic 61 CD# expression [001] 61 FDG uptake 61 vidofludimus 61 Pgp 61 HBsAg 61 antitumor efficacy 61 histone deacetylases 61 breast cancer subtypes 61 neovasculature 61 ADAM# 61 RAS MAPK pathway 61 EGFR pathway 61 ß catenin 61 anti leukemic 61 poly ADP ribose polymerase 61 MT1 MMP 61 NEUVENGE 61 LRP6 61 Rab5 61 effector memory 61 carcinomas 61 splice variant 61 molecularly targeted 61 miR #b [001] 61 TAp# 61 osteoblastic 61 immunohistochemical analysis 61 miR #b [002] 61 CHO cells 61 IGFBP 61 cyclin dependent kinase inhibitor 61 nutlin 3a 61 vorinostat 61 pathophysiological effects 61 CTAP# Capsules 61 protease activated 61 BMS# 61 TCF#L# 61 ERa 61 lung metastases 61 Bendavia 61 GBM tumors 61 cyclin D1 61 LRP5 61 β catenin 61 PKC isoforms 61 KRAS status 61 multiple myeloma MM 61 apoptotic pathway 61 Liposomal 61 estrogen receptor 61 antitumor effects 61 KRAS mutation 61 gene inactivation 61 Ceflatonin 61 supernatants 61 leukemic cells 61 tenascin C 61 cell adhesion molecules 61 Bortezomib 61 Enzastaurin 61 novel peptide 61 tumor vasculature 61 quantitative RT PCR 61 costimulation 61 EGFR inhibition 61 proteasome inhibitor 61 potent antitumor activity 61 fusion proteins 61 #T# L1 61 Aromatase 61 monoclonal anti 61 bortezomib 61 irreversible inhibitor 61 Solorel TM 61 RAR beta 61 epithelial cell 61 MEK1 61 mitogenic 61 humanized monoclonal antibodies 61 cytokines IL 60 PPARg 60 hA# 60 MMP2 60 heparanase 60 enzastaurin 60 Ganetespib 60 decitabine 60 Janus kinase 60 BRAF V#E 60 60 interleukin IL -6 60 histone deacetylase inhibitor 60 KIT mutations 60 rhIL 7 60 PHD2 60 liposomal formulation 60 lactate dehydrogenase LDH 60 bactericidal activity 60 inducible nitric oxide synthase 60 SERMs 60 ESBA# 60 dimerization 60 Debio 60 tumor hypoxia 60 sCD# 60 ectopic expression 60 JAK3 60 immune modulating 60 TFPI 60 inflammatory cytokine 60 chemopreventive agent 60 ErbB1 60 lymphoid 60 mononuclear cells 60 Trastuzumab 60 neutralizing antibody 60 vascular endothelial cells 60 potent cytotoxic 60 Caveolin 1 60 GPR# [001] 60 serotonin synthesis 60 potently inhibited 60 anaplastic lymphoma kinase ALK 60 prostate cancer AIPC 60 serotonin receptor 60 Wnt beta catenin 60 STAT1 60 metalloproteinase 60 DFMO 60 hepatocellular carcinoma HCC 60 JAK1 60 renal tumors 60 HIF PHI 60 stably transfected 60 Aplidin R 60 p# biomarker 60 immunotoxin 60 viral kinetics 60 PI3K/mTOR 60 Preclinical studies 60 protein kinase inhibitor 60 imatinib Gleevec 60 p# INK4a 60 ABCB1 60 mAb 60 soluble receptor 60 ERK phosphorylation 60 chemotherapeutic drug 60 HuR 60 BiTE 60 overexpressed 60 castration resistant prostate cancer 60 Tumor Necrosis Factor 60 Ocrelizumab 60 HER2 amplification 60 gastric carcinomas 60 MDSCs 60 ANG# 60 HER2 neu 60 LDL receptor 60 TLR3 60 GPC3 60 GSTP1 60 apolipoprotein B 60 CR# vcMMAE 60 angiogenesis inhibitor 60 Monocytes 60 Activating mutations 60 mRCC 60 cytotoxic T 60 cell lymphoma CTCL 60 HuMax EGFr 60 FGFR3 60 VitiGam 60 hepatocellular carcinoma 60 Flt3 60 GFAP 60 Lyn kinase 60 gemcitabine carboplatin 60 CDK inhibitor 60 AGTR1 60 RhoA 60 IFN beta 60 PTPN# 60 colorectal adenocarcinoma 60 pharmacodynamic biomarkers 60 protein tyrosine phosphatases 60 PKC delta 60 antisense inhibitors 60 adipogenic 60 HSP# inhibitor 60 HDAC inhibitors 60 glioblastoma multiforme GBM 60 MDR1 60 immunological responses 60 phosphorylated 60 proteinase 60 IMA# 60 MEK inhibitors 60 ALB # 60 antitumor effect 60 bispecific 60 CD9 60 estrogen receptors 60 thyroid hormone receptor 60 PPARγ 60 pleiotropic 60 N methyl 60 p# mutations 60 Kinase Inhibitor 60 cytochrome P 60 small molecule inhibitors 60 vivo 60 leukemic cell 60 prognostic indicator 60 polyclonal antibody 60 p# subunit 60 M1 muscarinic 60 tyrosine phosphorylation 60 Diffuse Large B 60 selectively binds 60 TLR9 agonist 60 HbF 60 endocrine therapies 60 N Myc 60 metastatic lesions 60 Lp PLA 2 60 inverse agonist 60 tyrosine kinase inhibitors 60 kinase inhibition 60 PAR1 60 mononuclear 60 mTOR pathway 60 telomerase inhibitor 60 liver metastases 60 HER2 HER2 60 specific membrane antigen 60 neurite outgrowth 60 autoantibodies 60 ZFN modified 60 GRK2 60 chemotherapeutic agent 60 endometrial adenocarcinoma 60 RIP1 60 RANKL 60 Erlotinib 60 haematopoietic 60 monoclonal antibody mAb 60 CD8 responses 60 IgM 60 neoadjuvant chemotherapy 60 matrix metalloproteinases 60 breast carcinoma 60 Leydig cell 60 cleavable linker 60 tumor cells 60 humoral immune response 60 #T# tumor 60 human tumor xenografts 60 HepaLife PICM 60 induce apoptosis 60 JAK2 60 IgG4 60 receptor tyrosine kinase inhibitor 60 myeloid cells 60 inhibitory activity 60 missense mutations 60 azacytidine 60 Endometrial 60 beta actin 60 GLI1 60 Her-2/neu 60 basophils 60 constitutively expressed 60 immunoconjugate 60 prostate cancer CaP 60 prostate cancer mCRPC 60 OMP #M# 60 PCa 60 VEGF inhibitors 60 effector functions 60 protein tyrosine phosphatase 60 immunomodulation 60 membrane receptors 60 colorectal carcinomas 60 dsRNA 60 shRNAs 60 agonism 60 annexin 60 trophoblast cells 60 isoenzyme 60 vascular disrupting agents 60 CBLC# 60 sequence homology 60 targeted antifolate 60 antitumoral 60 gastric adenocarcinoma 60 murine models 60 IFN g 60 ribonucleotide reductase clinically validated 60 PKM2 60 glycan structures 60 urothelial carcinoma 60 chemically modified siRNA 60 Solid Tumors 60 multikinase inhibitor 60 liposomal doxorubicin 60 DLC1 60 monocyte 60 #HT#A 60 p# mitogen activated 60 LTB4 60 alpha7 60 vinca alkaloid 60 RASSF1A 60 florbetaben 60 transcriptional activation 60 DNMT1 60 hepatocyte 60 TGF β1 60 tumor necrosis 60 calcitriol 60 neoplastic 60 HLA antibody 60 HERmark 60 immunohistochemistry IHC 60 Vidofludimus 60 heterodimers 60 Tubulin 60 viral antigens 60 CXCR4 expression 60 proteolytic cleavage 60 chemoresistance 60 Tarvacin 60 KineMarker TM 60 thrombopoietin 60 potent inhibitors 60 ELISpot 60 hypermethylated 60 macrophage colony stimulating 60 microRNA expression 60 regulated kinase ERK 60 ERK pathway 60 isoform selective 60 teriflunomide 60 oral JAK1 60 interleukins 60 somatostatin analogue 60 immune stimulatory 60 pertuzumab 60 ENaC 60 histologically 60 EGFR TKIs 60 cerebrospinal fluid CSF 60 cytokine IL 60 ADPKD 60 HGPIN 60 clonogenic 59 Monoclonal Antibody 59 proteoglycan 59 antisense oligonucleotide 59 mucinous 59 immunofluorescence 59 pegylated liposomal doxorubicin

Back to home page